{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:35:56Z","timestamp":1792888556248,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the project of scientific and technological innovation guidance program in the medical and health field of Zhengzhou","award":["2025YLZDJH275"],"award-info":[{"award-number":["2025YLZDJH275"]}]},{"name":"the Henan province science and technology research project","award":["252102311178 and 252102311186"],"award-info":[{"award-number":["252102311178 and 252102311186"]}]},{"name":"the 2628 talent enhancement project - three heroes talent program","award":["2025YYXM32"],"award-info":[{"award-number":["2025YYXM32"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00210-026-05716-9","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T03:17:40Z","timestamp":1784171860000},"page":"21119-21136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pan-cancer characterization of the pyrimidine catabolic enzyme UPB1 identifies a tumor-suppressive prognostic biomarker in skin cutaneous melanoma"],"prefix":"10.1007","volume":"399","author":[{"given":"Yingli","family":"Men","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiting","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinsen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"5716_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2024.11.006","volume":"36","author":"T Amaral","year":"2025","unstructured":"Amaral T, Ottaviano M, Arance A et al (2025) Cutaneous melanoma: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol 36:10\u201330. https:\/\/doi.org\/10.1016\/j.annonc.2024.11.006","journal-title":"Ann Oncol"},{"key":"5716_CR2","doi-asserted-by":"publisher","unstructured":"Cancer Genome Atlas Research Network (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513:202\u2013209. https:\/\/doi.org\/10.1038\/nature13480","DOI":"10.1038\/nature13480"},{"key":"5716_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar DS, Karthikeyan SK, Korla PK et al (2022) UALCAN: an update to the integrated cancer data analysis platform. Neoplasia 25:18\u201327. https:\/\/doi.org\/10.1016\/j.neo.2022.01.001","journal-title":"Neoplasia"},{"key":"5716_CR4","doi-asserted-by":"publisher","first-page":"6059","DOI":"10.1158\/0008-5472.CAN-17-2705","volume":"78","author":"C Cubuk","year":"2018","unstructured":"Cubuk C, Hidalgo MR, Amadoz A et al (2018) Gene expression integration into pathway modules reveals a pan-cancer metabolic landscape. Cancer Res 78:6059\u20136072. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-2705","journal-title":"Cancer Res"},{"key":"5716_CR5","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/s1734-1140(12)70919-2","volume":"64","author":"J Fidlerova","year":"2012","unstructured":"Fidlerova J, Kleiblova P, Kormunda S et al (2012) Contribution of the \u03b2-ureidopropionase (UPB1) gene alterations to the development of fluoropyrimidine-related toxicity. Pharmacol Rep 64:1234\u20131242. https:\/\/doi.org\/10.1016\/s1734-1140(12)70919-2","journal-title":"Pharmacol Rep"},{"key":"5716_CR6","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U et al (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6:pl1. https:\/\/doi.org\/10.1126\/scisignal.2004088","journal-title":"Sci Signal"},{"key":"5716_CR7","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3322\/caac.21409","volume":"67","author":"JE Gershenwald","year":"2017","unstructured":"Gershenwald JE, Scolyer RA, Hess KR et al (2017) Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 67:472\u2013492. https:\/\/doi.org\/10.3322\/caac.21409","journal-title":"CA Cancer J Clin"},{"key":"5716_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0292483","volume":"18","author":"A Hillowe","year":"2023","unstructured":"Hillowe A, Gordon C, Wang L et al (2023) Fatty acid binding protein 5 regulates docetaxel sensitivity in taxane-resistant prostate cancer cells. PLoS ONE 18:e0292483. https:\/\/doi.org\/10.1371\/journal.pone.0292483","journal-title":"PLoS ONE"},{"key":"5716_CR9","doi-asserted-by":"publisher","unstructured":"Hishinuma E, Guti\u00e9rrez Rico E, Hiratsuka M (2020) In vitro assessment of fluoropyrimidine-metabolizing enzymes: dihydropyrimidine dehydrogenase, dihydropyrimidinase, and \u03b2-ureidopropionase. J Clin Med 9. https:\/\/doi.org\/10.3390\/jcm9082342","DOI":"10.3390\/jcm9082342"},{"key":"5716_CR10","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41588-022-01100-4","volume":"54","author":"I Joanito","year":"2022","unstructured":"Joanito I, Wirapati P, Zhao N et al (2022) Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer. Nat Genet 54:963\u2013975. https:\/\/doi.org\/10.1038\/s41588-022-01100-4","journal-title":"Nat Genet"},{"key":"5716_CR11","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1001\/jama.2025.13074","volume":"334","author":"UM Joshi","year":"2025","unstructured":"Joshi UM, Kashani-Sabet M, Kirkwood JM (2025) Cutaneous melanoma: a review. JAMA 334:2113\u20132125. https:\/\/doi.org\/10.1001\/jama.2025.13074","journal-title":"JAMA"},{"key":"5716_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/mdr2.70040","volume":"1","author":"X Ke","year":"2025","unstructured":"Ke X, Li K, Jiang A et al (2025) Cloud-based GWAS platform: an innovative solution for efficient acquisition and analysis of genomic data. Med Res 1:397\u2013411. https:\/\/doi.org\/10.1002\/mdr2.70040","journal-title":"Med Res"},{"key":"5716_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00270","volume":"8","author":"S Kitano","year":"2018","unstructured":"Kitano S, Nakayama T, Yamashita M (2018) Biomarkers for immune checkpoint inhibitors in melanoma. Front Oncol 8:270. https:\/\/doi.org\/10.3389\/fonc.2018.00270","journal-title":"Front Oncol"},{"key":"5716_CR14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1186\/s12885-016-2826-8","volume":"16","author":"T Kunicka","year":"2016","unstructured":"Kunicka T, Prochazka P, Krus I et al (2016) Molecular profile of 5-fluorouracil pathway genes in colorectal carcinoma. BMC Cancer 16:795. https:\/\/doi.org\/10.1186\/s12885-016-2826-8","journal-title":"BMC Cancer"},{"key":"5716_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1182\/blood-2010-03-275305","volume":"117","author":"BJ Lannutti","year":"2011","unstructured":"Lannutti BJ, Meadows SA, Herman SEM et al (2011) CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability. Blood 117:591\u2013594. https:\/\/doi.org\/10.1182\/blood-2010-03-275305","journal-title":"Blood"},{"key":"5716_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04811-5","volume":"7","author":"B Li","year":"2017","unstructured":"Li B, Feng W, Luo O et al (2017) Development and validation of a three-gene prognostic signature for patients with hepatocellular carcinoma. Sci Rep 7:5517. https:\/\/doi.org\/10.1038\/s41598-017-04811-5","journal-title":"Sci Rep"},{"key":"5716_CR17","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z et al (2020) TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res 48:W509\u2013W514. https:\/\/doi.org\/10.1093\/nar\/gkaa407","journal-title":"Nucleic Acids Res"},{"key":"5716_CR18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/JIR.S440295","volume":"17","author":"Y Li","year":"2024","unstructured":"Li Y, Jiang M, Wei Y et al (2024) Integrative analyses of pyrimidine salvage pathway-related genes revealing the associations between UPP1 and tumor microenvironment. J Inflamm Res 17:101\u2013119. https:\/\/doi.org\/10.2147\/JIR.S440295","journal-title":"J Inflamm Res"},{"key":"5716_CR19","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu J, Lichtenberg T, Hoadley KA et al (2018) An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell 173:400-416.e11. https:\/\/doi.org\/10.1016\/j.cell.2018.02.052","journal-title":"Cell"},{"key":"5716_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac558","volume":"24","author":"C-J Liu","year":"2023","unstructured":"Liu C-J, Hu F-F, Xie G-Y et al (2023) GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief Bioinform 24:bbac558. https:\/\/doi.org\/10.1093\/bib\/bbac558","journal-title":"Brief Bioinform"},{"key":"5716_CR21","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/sj.bjc.6602678","volume":"93","author":"LM McShane","year":"2005","unstructured":"McShane LM, Altman DG, Sauerbrei W et al (2005) Reporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer 93:387\u2013391. https:\/\/doi.org\/10.1038\/sj.bjc.6602678","journal-title":"Br J Cancer"},{"key":"5716_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0344-8","volume":"6","author":"C Morrison","year":"2018","unstructured":"Morrison C, Pabla S, Conroy JM et al (2018) Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden. J Immunother Cancer 6:32. https:\/\/doi.org\/10.1186\/s40425-018-0344-8","journal-title":"J Immunother Cancer"},{"key":"5716_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41568-023-00557-7","volume":"23","author":"NJ Mullen","year":"2023","unstructured":"Mullen NJ, Singh PK (2023) Nucleotide metabolism: a pan-cancer metabolic dependency. Nat Rev Cancer 23:275\u2013294. https:\/\/doi.org\/10.1038\/s41568-023-00557-7","journal-title":"Nat Rev Cancer"},{"key":"5716_CR24","doi-asserted-by":"publisher","first-page":"7711","DOI":"10.3390\/curroncol31120568","volume":"31","author":"E Pelosi","year":"2024","unstructured":"Pelosi E, Castelli G, Testa U (2024) Braf-mutant melanomas: biology and therapy. Curr Oncol 31:7711\u20137737. https:\/\/doi.org\/10.3390\/curroncol31120568","journal-title":"Curr Oncol"},{"key":"5716_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1158\/2326-6066.CIR-17-0201","volume":"6","author":"J-K Rhee","year":"2018","unstructured":"Rhee J-K, Jung YC, Kim KR et al (2018) Impact of tumor purity on immune gene expression and clustering analyses across multiple cancer types. Cancer Immunol Res 6:87\u201397. https:\/\/doi.org\/10.1158\/2326-6066.CIR-17-0201","journal-title":"Cancer Immunol Res"},{"key":"5716_CR26","doi-asserted-by":"publisher","unstructured":"Savino A, De Marzo N, Provero P, Poli V (2021) Meta-analysis of microdissected breast tumors reveals genes regulated in the stroma but hidden in bulk analysis. Cancers (Basel) 13. https:\/\/doi.org\/10.3390\/cancers13133371","DOI":"10.3390\/cancers13133371"},{"key":"5716_CR27","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.cell.2014.07.032","volume":"158","author":"YD Shaul","year":"2014","unstructured":"Shaul YD, Freinkman E, Comb WC et al (2014) Dihydropyrimidine accumulation is required for the epithelial-mesenchymal transition. Cell 158:1094\u20131109. https:\/\/doi.org\/10.1016\/j.cell.2014.07.032","journal-title":"Cell"},{"key":"5716_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.36","volume":"1","author":"W Shen","year":"2022","unstructured":"Shen W, Song Z, Zhong X et al (2022) Sangerbox: a comprehensive, interaction-friendly clinical bioinformatics analysis platform. Imeta 1:e36. https:\/\/doi.org\/10.1002\/imt2.36","journal-title":"Imeta"},{"key":"5716_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.02.005","volume":"35","author":"A Siddiqui","year":"2020","unstructured":"Siddiqui A, Ceppi P (2020) A non-proliferative role of pyrimidine metabolism in cancer. Mol Metab 35:100962. https:\/\/doi.org\/10.1016\/j.molmet.2020.02.005","journal-title":"Mol Metab"},{"key":"5716_CR30","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1158\/1078-0432.CCR-16-2211","volume":"23","author":"BH Sohn","year":"2017","unstructured":"Sohn BH, Hwang J-E, Jang H-J et al (2017) Clinical significance of four molecular subtypes of gastric cancer identified by the cancer genome atlas project. Clin Cancer Res 23:4441\u20134449. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-2211","journal-title":"Clin Cancer Res"},{"key":"5716_CR31","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1080\/15384101.2021.1947567","volume":"20","author":"A Sporrij","year":"2021","unstructured":"Sporrij A, Zon LI (2021) Nucleotide stress responses in neural crest cell fate and melanoma. Cell Cycle 20:1455\u20131467. https:\/\/doi.org\/10.1080\/15384101.2021.1947567","journal-title":"Cell Cycle"},{"key":"5716_CR32","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C et al (2019) GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res 47:W556\u2013W560. https:\/\/doi.org\/10.1093\/nar\/gkz430","journal-title":"Nucleic Acids Res"},{"key":"5716_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.00172","volume":"7","author":"I Vanni","year":"2020","unstructured":"Vanni I, Tanda ET, Dalmasso B et al (2020) Non-BRAF mutant melanoma: molecular features and therapeutical implications. Front Mol Biosci 7:172. https:\/\/doi.org\/10.3389\/fmolb.2020.00172","journal-title":"Front Mol Biosci"},{"key":"5716_CR34","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"SV Vasaikar","year":"2018","unstructured":"Vasaikar SV, Straub P, Wang J, Zhang B (2018) LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res 46:D956\u2013D963. https:\/\/doi.org\/10.1093\/nar\/gkx1090","journal-title":"Nucleic Acids Res"},{"key":"5716_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.684961","volume":"11","author":"W Wang","year":"2021","unstructured":"Wang W, Cui J, Ma H et al (2021) Targeting pyrimidine metabolism in the era of precision cancer medicine. Front Oncol 11:684961. https:\/\/doi.org\/10.3389\/fonc.2021.684961","journal-title":"Front Oncol"},{"key":"5716_CR36","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature09882","volume":"471","author":"RM White","year":"2011","unstructured":"White RM, Cech J, Ratanasirintrawoot S et al (2011) DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature 471:518\u2013522. https:\/\/doi.org\/10.1038\/nature09882","journal-title":"Nature"},{"key":"5716_CR37","doi-asserted-by":"publisher","unstructured":"Wigle TJ, Tsvetkova EV, Welch SA, Kim RB (2019) DPYD and fluorouracil-based chemotherapy: mini review and case report. Pharmaceutics 11. https:\/\/doi.org\/10.3390\/pharmaceutics11050199","DOI":"10.3390\/pharmaceutics11050199"},{"key":"5716_CR38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13045-022-01263-x","volume":"15","author":"H-L Wu","year":"2022","unstructured":"Wu H-L, Gong Y, Ji P et al (2022) Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy. J Hematol Oncol 15:45. https:\/\/doi.org\/10.1186\/s13045-022-01263-x","journal-title":"J Hematol Oncol"},{"key":"5716_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.707677","volume":"9","author":"R Yang","year":"2021","unstructured":"Yang R, Wang Z, Li J et al (2021) The identification of the metabolism subtypes of skin cutaneous melanoma associated with the tumor microenvironment and the immunotherapy. Front Cell Dev Biol 9:707677. https:\/\/doi.org\/10.3389\/fcell.2021.707677","journal-title":"Front Cell Dev Biol"},{"key":"5716_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E et al (2013) Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 4:2612. https:\/\/doi.org\/10.1038\/ncomms3612","journal-title":"Nat Commun"},{"key":"5716_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-48961-1","volume":"13","author":"S Zhang","year":"2023","unstructured":"Zhang S, Gu J, Shi L-L et al (2023) A pan-cancer analysis of anti-proliferative protein family genes for therapeutic targets in cancer. Sci Rep 13:21607. https:\/\/doi.org\/10.1038\/s41598-023-48961-1","journal-title":"Sci Rep"},{"key":"5716_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18408","volume":"28","author":"P Zhang","year":"2024","unstructured":"Zhang P, Yang Z, Liu Z et al (2024) Deciphering lung adenocarcinoma evolution: integrative single-cell genomics identifies the prognostic lung progression associated signature. J Cell Mol Med 28:e18408. https:\/\/doi.org\/10.1111\/jcmm.18408","journal-title":"J Cell Mol Med"},{"key":"5716_CR43","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.1002\/tox.24230","volume":"39","author":"P Zhang","year":"2024","unstructured":"Zhang P, Wu X, Wang D et al (2024) Unraveling the role of low-density lipoprotein-related genes in lung adenocarcinoma: insights into tumor microenvironment and clinical prognosis. Environ Toxicol 39:4479\u20134495. https:\/\/doi.org\/10.1002\/tox.24230","journal-title":"Environ Toxicol"},{"key":"5716_CR44","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/PAI.0000000000001159","volume":"32","author":"L Zhang","year":"2024","unstructured":"Zhang L, Liu J, Wang H et al (2024) Low UPB1 level correlates with poor prognosis in lung adenocarcinoma. Appl Immunohistochem Mol Morphol 32:44\u201352. https:\/\/doi.org\/10.1097\/PAI.0000000000001159","journal-title":"Appl Immunohistochem Mol Morphol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05716-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05716-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05716-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:02:29Z","timestamp":1792886549000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05716-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":44,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["5716"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05716-9","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"15 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}